Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04279392 · ClinicalTrials.gov registry record · Phase 1
Healthy Body, Healthy Bones After Bariatric Surgery Trial
A Phase 1 study, sponsored by University of Nebraska.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT04279392 is a Phase 1 study that has completed, run by University of Nebraska. The registered enrollment target is 10 participants.
The verdict
NCT04279392, a Phase 1 study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
One in three adults in the United States suffers from obesity. Bariatric surgery is an increasingly utilized and effective treatment for obesity and obesity-related comorbidities, however, the massive weight loss associated with bariatric surgery adversely affects bone leads to an increased risk of fracture. Bisphosphonate medications, such as zoledronic acid, are used to treat bone loss in patients with osteoporosis, and this study investigates whether this medication can prevent bone loss associated with surgical weight loss procedures.
Interventions
- DRUG Placebos
- DRUG Zoledronic Acid 5 mg/Bag 100 ml Inj
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2022-12-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04279392
The ClinicalTrials.gov registry entry for NCT04279392 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebos is the first listed.
NCT04279392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04279392 about?
NCT04279392 is a clinical study titled "Healthy Body, Healthy Bones After Bariatric Surgery Trial". One in three adults in the United States suffers from obesity. Bariatric surgery is an increasingly utilized and effective treatment for obesity and obesity-related comorbidities, however, the massive weight loss associated with bariatric surgery adversely affects bone leads to an increased risk of ...
What is the current status of trial NCT04279392?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2020-09-01. Estimated completion is 2022-12-30.
What interventions are being tested in trial NCT04279392?
The interventions under investigation include: Placebos (DRUG), Zoledronic Acid 5 mg/Bag 100 ml Inj (DRUG).
Who is sponsoring clinical trial NCT04279392?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.